The funding will allow 52North to move its products, including its Neutrocheck point-of-care device, toward commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback